What happens to patent applications under secrecy orders in interference proceedings?

Patent applications under secrecy orders are treated differently in interference proceedings. According to MPEP 2306: “An interference will not be declared involving a national application under secrecy order. An applicant whose application is under secrecy order may suggest an interference (ยง 41.202(a) of this title), but the Office will not act on the request while…

Read More

Where can I find a sample Sequence Listing XML file?

A sample Sequence Listing XML file is available for reference. According to MPEP 2418: A sample sequence listing (XML file) specimen can be found in WIPO Standard ST.26, Annex III and at www.wipo.int/standards/en/xml_material/st26/st26-annex-iii-sequence-listing-specimen.xml. This sample file can be useful for understanding the structure and content of a compliant Sequence Listing XML file under WIPO Standard…

Read More

What statements are required when submitting a replacement Sequence Listing XML?

When submitting a replacement Sequence Listing XML for a patent application, several statements are required according to MPEP 2416. These statements ensure compliance with USPTO regulations and maintain the integrity of the application. The required statements include: A statement that identifies the location of all additions, deletions, or replacements of sequence information in the replacement…

Read More

What sequences must be included in the “Sequence Listing” of a patent application?

According to MPEP 2422.01, the following sequences must be included in the “Sequence Listing” of a patent application: All sequences, whether claimed or not, that meet the length thresholds in 37 CFR 1.821(a). Any sequence disclosed as a string of particular nucleotide bases or amino acids, regardless of whether the applicant considers it prior art.…

Read More

How are modified bases represented in nucleotide sequence listings?

According to MPEP 2422, modified bases in nucleotide sequence listings can be represented as follows: The modified base can be represented as the corresponding unmodified base in the sequence itself. The modification must be further described in numeric identifier <223> of the Feature section of the “Sequence Listing”. Specific symbols for modified bases may be…

Read More

Can a patent applicant rely on the reproduction of biological materials from a written description?

Yes, a patent applicant can potentially rely on the reproduction of biological materials from a written description, but there are important considerations. MPEP 2404 states: “The invention may rely on biological material which is known and readily available to the public or reproducible from the written description.” However, the applicant must ensure that: The written…

Read More

What is the Reexamination e-File and how does it differ from regular patent applications?

The Reexamination e-File is an electronic system that allows viewing of reexamination proceeding papers on the Image File Wrapper (IFW). According to MPEP 2635: “PALM provides information for the reexamination proceeding as to the patent owner and requester, contents, status, and related Office proceedings (applications, patents and reexamination proceedings). Some of the data entry for…

Read More